Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 … – PR Newswire (press release)
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 …PR Newswire (press release)12, 2016 /PRNewswire/ — Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a ne… Continue reading
